Cited by 272Endoplasmic Reticulum Stress and DiseaseRedox biology and oxidative stressCell death mechanisms and regulation

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

ATF4 is an oxidative stress–inducible, prodeath transcription factor in neurons in vitro and in vivo

Open access
Lange, Philipp S., Chavez, Juan C., Pinto, John T., Coppola, Giovanni, Sun, Chiao-Wang, Townes, Tim M., Geschwind, Daniel H., Ratan, Rajiv R.·2008·The Journal of Experimental Medicine

Abstract

Oxidative stress is pathogenic in neurological diseases, including stroke. The identity of oxidative stress–inducible transcription factors and their role in propagating the death cascade are not well known. In an in vitro model of oxidative stress, the expression of the bZip transcription factor activating transcription factor 4 (ATF4) was induced by glutathione depletion and localized to the promoter of a putative death gene in neurons. Germline deletion of ATF4 resulted in a profound reduction in oxidative stress–induced gene expression and resistance to oxidative death. In neurons, ATF4 modulates an early, upstream event in the death pathway, as resistance to oxidative death by ATF4 deletion was associated with decreased consumption of the antioxidant glutathione. Forced expression of ATF4 was sufficient to promote cell death and loss of glutathione. In ATF4−/− neurons, restoration of ATF4 protein expression reinstated sensitivity to oxidative death. In addition, ATF4−/− mice experienced significantly smaller infarcts and improved behavioral recovery as compared with wild-type mice subjected to the same reductions in blood flow in a rodent model of ischemic stroke. Collectively, these findings establish ATF4 as a redox-regulated, prodeath transcriptional activator in the nervous system that propagates death responses to oxidative stress in vitro and to stroke in vivo.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1084/jem.20071460

Cites

0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Show all 3 references

Research works printed but not linked: 56

  1. 2002, Physiol. Rev., 82, 47, 10.1152/physrev.00018.2001 · DOI · Paper page
  2. 2006, Int. J. Biochem. Cell Biol., 38, 317, 10.1016/j.biocel.2005.09.018 · DOI · Paper page
  3. 2000, Ann. NY Acad. Sci., 924, 164, 10.1111/j.1749-6632.2000.tb05575.x · DOI
  4. 2007, FEBS Lett., 581, 3634, 10.1016/j.febslet.2007.04.028 · DOI
  5. 2007, Mol. Cell., 26, 1, 10.1016/j.molcel.2007.03.016 · DOI · Paper page
  6. 2003, J. Neurosci., 23, 3597, 10.1523/JNEUROSCI.23-09-03597.2003 · DOI
  7. 1997, J. Biol. Chem., 272, 24088, 10.1074/jbc.272.38.24088 · DOI
  8. 2001, Gene., 273, 1, 10.1016/S0378-1119(01)00551-0 · DOI
  9. 2006, Cancer Biol. Ther., 5, 723
  10. 2003, Mol. Cell., 11, 619, 10.1016/S1097-2765(03)00105-9 · DOI
  11. 1998, J. Neurosci., 18, 4083, 10.1523/JNEUROSCI.18-11-04083.1998 · DOI
  12. 2002, Methods Enzymol., 352, 183, 10.1016/S0076-6879(02)52018-8 · DOI
  13. 1994, J. Neurochem., 62, 376, 10.1046/j.1471-4159.1994.62010376.x · DOI
  14. 1995, Clin. Exp. Pharmacol. Physiol., 22, 309, 10.1111/j.1440-1681.1995.tb02006.x · DOI
  15. 1996, Neurochem. Int., 29, 153, 10.1016/0197-0186(95)00115-8 · DOI
  16. 2004, J. Nutr., 134, 2812S, 10.1093/jn/134.10.2812S · DOI
  17. 2003, J. Biol. Chem., 278, 37375, 10.1074/jbc.M303619200 · DOI
  18. 2002, Blood., 99, 736, 10.1182/blood.V99.3.736 · DOI
  19. 1994, J. Neurosci., 14, 4385, 10.1523/JNEUROSCI.14-07-04385.1994 · DOI
  20. 2005, J. Cereb. Blood Flow Metab., 25, 41, 10.1038/sj.jcbfm.9600005 · DOI
  21. 2007, J. Biol. Chem., 282, 4634, 10.1074/jbc.M609388200 · DOI
  22. 2007, J. Neurosci., 27, 6320, 10.1523/JNEUROSCI.0449-07.2007 · DOI
  23. 2003, J. Biol. Chem., 278, 17421, 10.1074/jbc.M300761200 · DOI
  24. 1998, Genes Cells., 3, 801, 10.1046/j.1365-2443.1998.00230.x · DOI
  25. 2000, Dev. Biol., 222, 110, 10.1006/dbio.2000.9699 · DOI
  26. 2001, Neuron., 29, 563, 10.1016/S0896-6273(01)00232-X · DOI
  27. 2000, Mol. Cell., 6, 1099, 10.1016/S1097-2765(00)00108-8 · DOI
  28. 2003, Dev. Cell., 4, 442, 10.1016/S1534-5807(03)00100-X · DOI
  29. 2002, J. Biol. Chem., 277, 24120, 10.1074/jbc.M201959200 · DOI
  30. 2001, J. Cell Biol., 153, 1011, 10.1083/jcb.153.5.1011 · DOI
  31. 2001, Mol. Cell. Biol., 21, 2192, 10.1128/MCB.21.6.2192-2202.2001 · DOI
  32. 2006, Ann. NY Acad. Sci., 1068, 131, 10.1196/annals.1346.027 · DOI
  33. 1992, Proc. Natl. Acad. Sci. USA., 89, 4820, 10.1073/pnas.89.11.4820 · DOI
  34. 1995, Cell., 83, 979, 10.1016/0092-8674(95)90213-9 · DOI · Paper page
  35. 2001, J. Biol. Chem., 276, 20858, 10.1074/jbc.M101198200 · DOI
  36. 2003, Curr. Pharm. Des., 9, 2499, 10.2174/1381612033453730 · DOI
  37. 2004, Mol. Cell. Biol., 24, 9456, 10.1128/MCB.24.21.9456-9469.2004 · DOI
  38. 2004, Cell., 117, 387, 10.1016/S0092-8674(04)00344-7 · DOI
  39. 2004, J. Biol. Chem., 279, 5288, 10.1074/jbc.M311862200 · DOI
  40. 2005, EMBO J., 24, 1243, 10.1038/sj.emboj.7600596 · DOI
  41. 2006, Proc. Natl. Acad. Sci. USA., 103, 768, 10.1073/pnas.0505723102 · DOI
  42. 1999, Biochem. Biophys. Res. Commun., 258, 260, 10.1006/bbrc.1999.0576 · DOI
  43. 2004, EMBO J., 23, 169, 10.1038/sj.emboj.7600030 · DOI
  44. 2006, J. Biomed. Sci., 13, 205, 10.1007/s11373-005-9057-3 · DOI
  45. 2006, Br. J. Haematol., 134, 145, 10.1111/j.1365-2141.2006.06132.x · DOI
  46. 2005, Curr. Med. Chem. Anticancer Agents., 5, 15, 10.2174/1568011053352587 · DOI
  47. 2004, J. Natl. Cancer Inst., 96, 1300, 10.1093/jnci/djh243 · DOI
  48. 2003, Cancer Res., 63, 8592
  49. 2006, Cell., 125, 971, 10.1016/j.cell.2006.05.012 · DOI
  50. 2005, J. Biol. Chem., 280, 30689, 10.1074/jbc.M500750200 · DOI
  51. 2006, J. Cereb. Blood Flow Metab., 26, 1465, 10.1038/sj.jcbfm.9600298 · DOI
  52. 2005, Nat. Rev. Neurosci., 6, 775
  53. 2005, J. Biol. Chem., 280, 41732, 10.1074/jbc.M504963200 · DOI
  54. 2005, J. Biol. Chem., 280, 3996, 10.1074/jbc.M409223200 · DOI
  55. 2004, Genome Biol., 5, R80, 10.1186/gb-2004-5-10-r80 · DOI
  56. 2006, J. Neurosci., 26, 9471, 10.1523/JNEUROSCI.2838-06.2006 · DOI

Cited by

Sorted by citations

Items 101–200 of 250

Metadata

Authors
Lange, P. S., Chavez, J. C., Pinto, J. T., Coppola, G., Sun, C.-W., Townes, T. M., Geschwind, D. H., & Ratan, R. R.
Affiliations
  • University of Bonn (DE)
  • Cornell University (US)
  • New York Medical College (US)
  • 6Program in Neurogenetics, Department of Neurology,
  • University of Alabama at Birmingham (US)
  • University of California, Los Angeles (US)
Venue
The Journal of Experimental Medicine
Published
2008-05-05
Volume
205
Issue
5
Pages
1227-1242
ISSN
  • 0022-1007 (ISSN-L)
  • 1540-9538
OpenAlex
W2105818495
Cited by
272
References
62
Citations by year
2026: 15 · 2025: 16 · 2024: 17 · 2023: 19 · 2022: 17 · 2021: 21 · 2020: 12 · 2019: 18 · 2018: 19 · 2017: 9 · 2016: 17 · 2015: 17 · 2014: 20 · 2013: 16 · 2012: 13
FWCI
3.79
Type
journal article
Language
en
Open access
Licence
cc-by-nc-sa
Locations
  • The Journal of Experimental Medicine (publishedVersion)
  • PubMed Central (publishedVersion, cc-by-nc-sa)
  • PubMed (publishedVersion)
  • eScholarship (California Digital Library) (submittedVersion, cc-by-nc-sa)
  • Touro Scholar (Touro College) (submittedVersion, cc-by-nc-sa)
  • eScholarship (California Digital Library) (submittedVersion)
Funders
  • American Heart Association
  • Dr. Miriam and Sheldon G. Adelson Medical Research Foundation
  • Burke Foundation
  • Deutsche Forschungsgemeinschaft
  • Universität zu Köln
  • National Institutes of Health
  • National Institute of Neurological Disorders and Stroke (R01NS040591, NS40591)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Endoplasmic Reticulum Stress and Disease
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
Keywords
ATF4, oxidative stress, neuronal cell death, transcription factors, glutathione depletion, ischemic stroke, infarct size, redox regulation, bZIP transcription factors, neuroprotection, stroke recovery
MeSH terms
Animals, Cell Nucleus, Cell Survival, Cells, Cultured, Cerebral Cortex, Chromatin, DNA, Neurons, Plasmids, Polymerase Chain Reaction, Leucine Zippers, Cell Death, Mice, Knockout, Oxidative Stress, Mice, Activating Transcription Factor 4

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review